Recombinant multi-species TFIIE Beta/GTF2E2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TFIIE Beta/GTF2E2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The general transcription factor IIE (TFIIE) is part of the RNA polymerase II transcription initiation complex, recruiting TFIIH and being essential for promoter clearance by RNA polymerase II. TFIIE is a heterodimer (and sometimes heterotetramer) of alpha and beta subunits. The protein encoded by this gene represents the beta subunit of TFIIE. [provided by RefSeq, Jan 2017]
The Alternative Names of target: 34kDa,C330006J08Rik,FE,GTF2E2,General transcription factor IIE subunit 2,Gtf2e2,TF2E2,TFIIE Beta,TFIIE-B,TFIIE-beta,TTD6,Transcription initiation factor IIE subunit beta
Go
to TFIIE Beta/GTF2E2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP7814-Ag-1/ GM-Tg-hg-IP7814-Ag-2 | Human TFIIE Beta/GTF2E2 protein | Human |
| GM-Tg-rg-IP7814-Ag-1/ GM-Tg-rg-IP7814-Ag-2 | Rat TFIIE Beta/GTF2E2 protein | Rat |
| GM-Tg-mg-IP7814-Ag-1/ GM-Tg-mg-IP7814-Ag-2 | Mouse TFIIE Beta/GTF2E2 protein | Mouse |
| GM-Tg-cynog-IP7814-Ag-1/ GM-Tg-cynog-IP7814-Ag-2 | Cynomolgus/Rhesus macaque TFIIE Beta/GTF2E2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP7814-Ag-1/ GM-Tg-felg-IP7814-Ag-2 | Feline TFIIE Beta/GTF2E2 protein | Feline |
| GM-Tg-cang-IP7814-Ag-1/ GM-Tg-cang-IP7814-Ag-2 | Canine TFIIE Beta/GTF2E2 protein | Canine |
| GM-Tg-bovg-IP7814-Ag-1/ GM-Tg-bovg-IP7814-Ag-2 | Bovine TFIIE Beta/GTF2E2 protein | Bovine |
| GM-Tg-equg-IP7814-Ag-1/ GM-Tg-equg-IP7814-Ag-2 | Equine TFIIE Beta/GTF2E2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP7814-Ag-1/ GM-Tg-hg-IP7814-Ag-2;
GM-Tg-rg-IP7814-Ag-1/ GM-Tg-rg-IP7814-Ag-2;
GM-Tg-mg-IP7814-Ag-1/ GM-Tg-mg-IP7814-Ag-2; GM-Tg-cynog-IP7814-Ag-1/ GM-Tg-cynog-IP7814-Ag-2; GM-Tg-felg-IP7814-Ag-1/ GM-Tg-felg-IP7814-Ag-2; GM-Tg-cang-IP7814-Ag-1/ GM-Tg-cang-IP7814-Ag-2; GM-Tg-bovg-IP7814-Ag-1/ GM-Tg-bovg-IP7814-Ag-2; GM-Tg-equg-IP7814-Ag-1/ GM-Tg-equg-IP7814-Ag-2 |
| Products Name | TFIIE Beta/GTF2E2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | TFIIE Beta/GTF2E2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TFIIE Beta/GTF2E2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.